NEW YORK, Feb 28 (Reuters) - Valeant Pharmaceuticals International said on Sunday that Chief Executive Officer Michael Pearson will return from medical leave effective immediately, and the drugmaker will postpone the release of fourth-quarter results planned for Monday.
Read more
No comments:
Post a Comment